Radiotherapy for High-grade T1 Bladder Cancer

Sophie E M Raby; Ananya Choudhury

doi:10.1016/j.euf.2018.07.017

Radiotherapy for High-grade T1 Bladder Cancer

Eur Urol Focus. 2018 Jul;4(4):506-508. doi: 10.1016/j.euf.2018.07.017. Epub 2018 Jul 20.

Authors

Sophie E M Raby¹, Ananya Choudhury²

Affiliations

¹ Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester M20 4BX, UK.
² Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester M20 4BX, UK; Division of Cancer Science, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester M13 9PL, UK. Electronic address: [email protected].

PMID: 30033069
DOI: 10.1016/j.euf.2018.07.017

Abstract

Radiotherapy is rarely used for T1 bladder cancer. We discuss the potential reasons for this, the current evidence, and make suggestions for future research. PATIENT SUMMARY: Despite its success in muscle-invasive disease, radiotherapy is rarely used for non-muscle-invasive bladder cancer. We discuss the current evidence and suggest that, with further research, radiotherapy holds much promise as a bladder-preserving strategy.

Keywords: Non–muscle-invasive bladder cancer; Radiotherapy; T1 bladder cancer.

Publication types

Review

MeSH terms

Combined Modality Therapy / methods
Humans
Neoplasm Grading
Neoplasm Invasiveness
Neoplasm Recurrence, Local*
Neoplasm Staging
Radiotherapy / methods*
Treatment Outcome
Urinary Bladder Neoplasms* / pathology
Urinary Bladder Neoplasms* / radiotherapy